Nutex Health 8-K Confirms NASDAQ Listing for Common Stock
Ticker: NUTX · Form: 8-K · Filed: Jan 11, 2024 · CIK: 1479681
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, corporate-governance
TL;DR
**Nutex Health filed an 8-K, confirming its common stock (NUTX) is still listed on NASDAQ.**
AI Summary
Nutex Health, Inc. filed an 8-K on January 11, 2024, to disclose general information, specifically noting its common stock, $0.001 par value, is traded on The NASDAQ Stock Market LLC under the symbol NUTX. This filing primarily serves to update administrative details and confirm its listing status. For investors, this matters because it reaffirms the company's compliance with SEC reporting requirements and its continued listing on a major exchange, which can impact liquidity and investor confidence.
Why It Matters
This filing confirms Nutex Health's continued compliance with SEC regulations and its listing on NASDAQ, which is crucial for maintaining investor access and market liquidity.
Risk Assessment
Risk Level: low — This 8-K filing is purely administrative and does not contain any information that would introduce new risks or significant changes to the company's operations or financial health.
Analyst Insight
This filing is purely administrative and does not provide new information warranting immediate action. Investors should continue to monitor operational and financial performance filings.
Key Numbers
- $0.001 — par value per share (par value of Nutex Health, Inc.'s common stock)
Key Players & Entities
- Nutex Health, Inc. (company) — registrant
- The NASDAQ Stock Market LLC (company) — exchange where securities are registered
- NUTX (company) — trading symbol for common stock
- $0.001 (dollar_amount) — par value of common stock
- January 11, 2024 (date) — date of earliest event reported and filing date
Forward-Looking Statements
- Nutex Health, Inc. will continue to be listed on The NASDAQ Stock Market LLC. (Nutex Health, Inc.) — high confidence, target: 2025-01-11
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is NUTEX HEALTH, INC.
On what date was the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was January 11, 2024.
What is the trading symbol for Nutex Health, Inc.'s common stock?
The trading symbol for Nutex Health, Inc.'s common stock is NUTX.
On which exchange is Nutex Health, Inc.'s common stock registered?
Nutex Health, Inc.'s common stock is registered on The NASDAQ Stock Market LLC.
What is the par value of Nutex Health, Inc.'s common stock?
The par value of Nutex Health, Inc.'s common stock is $0.001.
Filing Stats: 525 words · 2 min read · ~2 pages · Grade level 9.3 · Accepted 2024-01-11 10:59:19
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value NUTX The NASDAQ Stock Mar
Filing Documents
- nutx-20240111x8k.htm (8-K) — 29KB
- nutx-20240111xex99d1.htm (EX-99.1) — 53KB
- nutx-20240111xex99d1g001.jpg (GRAPHIC) — 170KB
- nutx-20240111xex99d1g002.jpg (GRAPHIC) — 355KB
- nutx-20240111xex99d1g003.jpg (GRAPHIC) — 281KB
- nutx-20240111xex99d1g004.jpg (GRAPHIC) — 53KB
- nutx-20240111xex99d1g005.jpg (GRAPHIC) — 253KB
- nutx-20240111xex99d1g006.jpg (GRAPHIC) — 332KB
- nutx-20240111xex99d1g007.jpg (GRAPHIC) — 187KB
- nutx-20240111xex99d1g008.jpg (GRAPHIC) — 257KB
- nutx-20240111xex99d1g009.jpg (GRAPHIC) — 280KB
- nutx-20240111xex99d1g010.jpg (GRAPHIC) — 247KB
- nutx-20240111xex99d1g011.jpg (GRAPHIC) — 228KB
- nutx-20240111xex99d1g012.jpg (GRAPHIC) — 187KB
- nutx-20240111xex99d1g013.jpg (GRAPHIC) — 166KB
- nutx-20240111xex99d1g014.jpg (GRAPHIC) — 186KB
- nutx-20240111xex99d1g015.jpg (GRAPHIC) — 156KB
- nutx-20240111xex99d1g016.jpg (GRAPHIC) — 217KB
- nutx-20240111xex99d1g017.jpg (GRAPHIC) — 204KB
- nutx-20240111xex99d1g018.jpg (GRAPHIC) — 255KB
- nutx-20240111xex99d1g019.jpg (GRAPHIC) — 199KB
- nutx-20240111xex99d1g020.jpg (GRAPHIC) — 221KB
- nutx-20240111xex99d1g021.jpg (GRAPHIC) — 329KB
- nutx-20240111xex99d1g022.jpg (GRAPHIC) — 147KB
- nutx-20240111xex99d1g023.jpg (GRAPHIC) — 160KB
- nutx-20240111xex99d1g024.jpg (GRAPHIC) — 239KB
- nutx-20240111xex99d1g025.jpg (GRAPHIC) — 332KB
- 0001558370-24-000199.txt ( ) — 7992KB
- nutx-20240111.xsd (EX-101.SCH) — 4KB
- nutx-20240111_def.xml (EX-101.DEF) — 3KB
- nutx-20240111_lab.xml (EX-101.LAB) — 17KB
- nutx-20240111_pre.xml (EX-101.PRE) — 11KB
- nutx-20240111x8k_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On Thursday January 11, 2024, Tom Vo, M.D., MBA CEO and Chairman, and Warren Hosseinion, M.D., President of Nutex Health Inc. (the "Company"), are scheduled to present at the 42 nd Annual J.P. Morgan Healthcare Conference in San Francisco, California. A copy of the Company's presentation is furnished as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 99.1 Nutex Health Inc. Investor Presentation 104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. THE INFORMATION CONTAINED IN ITEM 7.01 OF THIS CURRENT REPORT, INCLUDING EXHIBIT 99.1 ATTACHED HERETO, SHALL NOT BE DEEMED "FILED" FOR THE PURPOSES OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, NOR SHALL IT BE DEEMED INCORPORATED BY REFERENCE INTO ANY REGISTRATION STATEMENT OR OTHER FILING PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, EXCEPT AS OTHERWISE EXPRESSLY STATED IN SUCH FILING. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: January 11, 2024 Nutex Health Inc. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer